Immix Biopharma (IMMX) Interest Coverage Ratio (2021 - 2026)
Immix Biopharma (IMMX) reported Interest Coverage Ratio of 30.29 for Q1 2026, down 182.38% on a YoY basis from 36.77 in Q1 2025, and down 6932.77% sequentially from 0.43 in Q4 2025.
Immix Biopharma (IMMX) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 6 years of Interest Coverage Ratio data on file, last reported at 30.29 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 182.38% year-over-year to 30.29; the trailing twelve-month figure through Mar 2026 stood at 101.15 (down 102.86% YoY), and the FY2025 full-year result was 1.18, up 17.65% from the prior year.
- Interest Coverage Ratio retreated to 30.29 in Q1 2026, from 0.43 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.32 in Q4 2024 to a low of 8259.02 in Q2 2022.
- A 5-year average of 980.75 and a median of 7.89 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 182850.63% in 2022 and soared 55.09% in 2024, its largest moves.
- Tracing IMMX's Interest Coverage Ratio over 5 years: stood at 8259.02 in 2022, then surged by 99.99% to 0.7 in 2023, then soared by 55.09% to 0.32 in 2024, then tumbled by 36.15% to 0.43 in 2025, then slumped by 6932.77% to 30.29 in 2026.
- Business Quant data shows IMMX's Interest Coverage Ratio at 30.29 in Q1 2026, 0.43 in Q4 2025, and 5.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immix Biopharma | 487.25 Mn | 487.25 Mn | - | -30.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.29 |
| Dec 31, 2025 | -0.43 |
| Sep 30, 2025 | -5.09 |
| Jun 30, 2025 | -16.16 |
| Mar 31, 2025 | -10.73 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -4.72 |
| Jun 30, 2024 | -2.93 |
| Mar 31, 2024 | -10.70 |
| Dec 31, 2023 | -0.70 |
| Jun 30, 2022 | -8,259.02 |
| Mar 31, 2022 | -3,427.93 |
| Dec 31, 2021 | -1,009.00 |
| Sep 30, 2021 | -6.45 |
| Jun 30, 2021 | -4.51 |
| Mar 31, 2021 | -5.90 |